Sanofi Settles Obesity Drug Class Action For $40M
French pharmaceutical giant Sanofi-Aventis SA has agreed to pay $40 million to settle a class action brought by investors who claim the company withheld information about anti-obesity drug Zimulti's link to...To view the full article, register now.
Already a subscriber? Click here to view full article